Search
Now showing items 11-13 of 13
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
(Brac University, 2022-04)
A decade has passed since no new Alzheimer's disease (AD) therapies were approved, even
though it is the leading motive of dementia in the modern era. The community of patients with
AD leads to expansion. Anxiety, anger, ...
Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
(Brac University, 2022-04)
Purpose: Alzheimer's disease (AD) is a multifactorial neurodegenerative brain disorder that affects approximately 5.3 million people in the United States, including nearly half of the population aged 85 and up. It has ...
Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
(Brac University, 2022-11)
In neurology, Alzheimer's disease represents greatest unmet medical need. Formation of
neurofibrillary tangles, Amyloid Beta-peptide (Aβ) deposition, and significant oxidative
stress, synapse loss are features of the ...